Salubris Pharmaceuticals Invests in Yueguang Medical and Secures Exclusive Distribution Rights for Its Products

Original Title:Salubris: Capital increase and equity investment in Prudence Medical, along with acquisition of product agency and distribution rights Source: e Company

Salubris (002294) announced on the evening of March 24 that the Company and its subsidiary, Salubris Medtech, recently entered into a "Product Distribution Agreement" with Prudence Medical Technologies Ltd., securing exclusive distribution rights for Prudence Medical’s “Dynamic ECG Recorder,” “Atrial Fibrillation Patient Education Device,” and new products in the terminal market of secondary hospitals and above across China. Within the agreed term of the agreement, the Company will pay sales commissions to Prudence Medical at a certain ratio based on sales performance. Meanwhile, the Company and Prudence Medical, along with its shareholders, signed a capital increase agreement, under which the Company invested RMB 20.09 million to acquire a 9.43% equity stake in Prudence Medical.

(Original Title: Salubris: Capital Injection and Equity Stake in Prudence Medical, and Acquisition of Product Agency and Distribution Rights)